Drug
Pentetreotide clinical trials
Also written OctreoScan.
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 1999 (1)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
Radio Isotope Therapy of America (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Marcelo F. Di Carli, MD, FACC (1) · Mallinckrodt (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses pentetreotide is read from its arms, and is right about nine times in ten.
Testing it · 4
- Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine TumorsCompletedPhase 2/3Radio Isotope Therapy of AmericaNCT00442533Written as Indium-111 pentetreotide
- New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing SyndromeCompletedPhase 2Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00001849Written as Pentetreotide
- Somatostatin Receptor Imaging in Patients With Suspected Cardiac SarcoidosisCompletedNot applicableMarcelo F. Di Carli, MD, FACCNCT02546388Written as Indium-111 Pentreotide
- Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent TumorsTerminatedPhase 4MallinckrodtNCT00944372Written as Indium In-111 pentetreotide
Codes
What other systems call pentetreotide · ClinicalTrials.gg INT003733
- MeSH (NLM) C081788pentetreotideOne source NLM
- UNII (FDA) G083B71P98PENTETREOTIDEConfirmed FDA, NLM, Wikidata
- RxNorm 69893Confirmed FDA, Wikidata
- Wikidata Q24864045pentetreotideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66342PentetreotideOne source FDA
- DrugBank DB12602One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C081788 | pentetreotide | One source NLM |
| UNII (FDA) | G083B71P98 | PENTETREOTIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69893 | — | Confirmed FDA, Wikidata |
| Wikidata | Q24864045 | pentetreotide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66342 | Pentetreotide | One source FDA |
| DrugBank | DB12602 | — | One source Wikidata |
Also registered as indium in-111 pentetreotide (UNII M312JJ6Z32 · RxNorm 1724429).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.